These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension. Binder J, Kalafat E, Palmrich P, Pateisky P, Khalil A. Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812 [Abstract] [Full Text] [Related]
5. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes. Lai J, Syngelaki A, Nicolaides KH, von Dadelszen P, Magee LA. Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504 [Abstract] [Full Text] [Related]
12. Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia. March MI, Geahchan C, Wenger J, Raghuraman N, Berg A, Haddow H, Mckeon BA, Narcisse R, David JL, Scott J, Thadhani R, Karumanchi SA, Rana S. PLoS One; 2015 May; 10(5):e0126815. PubMed ID: 25965397 [Abstract] [Full Text] [Related]
14. The additive role of angiogenic markers for women with confirmed preeclampsia. Suresh S, Patel E, Mueller A, Morgan J, Lewandowski WL, Verlohren S, von Dadelszen P, Magee LA, Rana S. Am J Obstet Gynecol; 2023 May; 228(5):573.e1-573.e11. PubMed ID: 36356699 [Abstract] [Full Text] [Related]